See Also: Comparative genomic hybridization (CGH)(health)
Dioramax Inversiones, S.A., SICAV(finance)
H2 O2 Inversiones, SICAV, S.A.(finance)
Olh Inversiones, SICAV, S.A.(finance)
Boi de Inversiones, SICAV, S.A.(finance)
Help Inversiones, SICAV, S.A.(finance)
Hie de Inversiones, SICAV, S.A.(finance)
S.G. 2.000 Inversiones, SICAV, S.A.(finance)
Guaten de Inversiones, SICAV, S.A.(finance)
Guerfal Inversiones, SICAV, S.A.(finance)

Comparative genomic hybridization (CGH) (health) and Dioramax Inversiones, S.A., SICAV (finance)


Comparative genomic hybridization (CGH) (health)


A chromosomal screening technique that permits the detection of quantitative changes in chromosomal copy number without the need for cell culturing. It provides a global overview of chromosomal gains and losses throughout the whole genome (including extra, missing, and broken chromosomes), but cannot detect small changes in DNA sequence or changes in the imprinting state of a gene.





Dioramax Inversiones, S.A., SICAV (finance)


Dioramax Inversiones, S.A., SICAV is a Spanish company listed at Madrid Stock Exchange. Its business activity is capital investment.